AI system to improve ovarian tumor diagnosis before surgery
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study is testing an AI system that uses your ultrasound or MRI images and blood test results to help doctors better diagnose ovarian tumors before surgery. It may lead to more accurate treatment planning.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for surgery to remove an ovarian tumor.
- You have had an ultrasound or MRI of your ovaries within the last 3 months before surgery.
- You have blood test results for tumor markers (like CA-125) from the past 3 months.
- You have not received chemotherapy or radiation therapy for this tumor.
- This is your first diagnosis of an ovarian tumor, not a recurrence.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an AI system that helps doctors read ovarian ultrasound images more accurately. You might qualify if you had an ovarian mass seen on ultrasound, had it surgically removed, and have clear images and lab results.
This trial tests a computer program (artificial intelligence) that looks at CT scans of the pelvis to help find ovarian cancer. If it works, it could help doctors diagnose this cancer earlier and more accurately.
This study looks at results from surgery to remove as much advanced ovarian cancer as possible after chemotherapy. Participating hospitals are in Italy and Canada.
This trial tests a non-invasive, AI-based monitoring program for people with solid tumors. It aims to help track how you’re doing during or after curative-intent treatment, using information collected without extra procedures.
This trial uses artificial intelligence to analyze CT and MRI scans of solid tumors. The goal is to better understand how tumors respond to non-surgical treatments, which could help doctors make more personalized treatment decisions.
This trial is testing how well a special ultrasound model (ADNEX) can predict whether an ovarian tumor is benign or cancerous. It helps doctors make better decisions, and it’s for people with complex ovarian tumors who speak Dutch.
Hear when a new Ovarian Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.